Example: Heart Attack
Clinical Trials on Hyperlipoproteinemia Type 4
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- C Section
- Chronic Critical Ischemia
- Difference Between Femoral Nerve Block and Saphenous Block
- Exercise Testing With Music Pacing
- Hoarseness
- Infertile High-risk Patients With Polycystic Ovaries
- Non-Hodgkin's Disease
- Preeclampsia Severe
- Premature; Infant, Light-for-dates
- Root Canal Disinfection
- Segmental Transit Time
- Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.
- Von Hippel-Lindau Syndrome
- View Full List
Sponsors and Collaborators
- Anlu Puai Hospital
- Cardioangiologisches Centrum Bethanien
- Core Medical (Beijing) Co., Ltd.
- Government Calicut Medical College
- Institute of Parasitology and Biomedicine Lopez Neyra
- Medtronic Bakken Research Center
- National Center for Advancing Translational Science
- Phillip Low
- R.C.I. van Geenen, orthopedic surgeon, Amphia, Breda, The Netherlands
- RGöçmen
- The Neurobiology Research Unit at Copenhagen University Hospital Rigshospitalet
- The Pacific Link Consulting Co
- Zhiyuan Medical Inspection Institute
- View Full List
Drug Interventions
- 0.10 mL/kg DDFPe
- 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)
- Avigan
- Cohort 3
- DOCETAXEL (XRP6976)
- KPT-8602
- LY3076226
- Losartan + Simvastatin
- Placebo (NNC0480-0389)
- Placebo-matching Mifepristone
- Valproate sodium
- belladonna 16.2 mg and opium 60 mg suppository
- sequence of drug use
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations